[KTTA] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
30-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 14.91%
YoY- -719.37%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 976 241 15 0 -
PBT -5,031 -5,118 630 -48 371.48%
Tax 17 -1,215 0 0 -
NP -5,048 -3,902 630 -48 372.01%
Tax Rate - - -0.00% - -
Total Cost 6,024 4,143 -615 48 400.66%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -517.07 -1,621.19 4,183.53 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -4.85 -3.00 0.06 -0.13 234.14%
EPS Diluted -4.85 -3.00 0.06 -0.13 234.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.